Oncotarget

Research Papers:

Serine protease inhibitor kazal-type 6 inhibits tumorigenesis of human hepatocellular carcinoma cells via its extracellular action

Kuikui Ge, Jinjiang Huang, Wei Wang, Meigang Gu, Xinchuan Dai, Yuqiang Xu, Hongyu Wu, Guodong Li, Hairong Lu, Jiang Zhong and Qingshan Huang _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:5965-5975. https://doi.org/10.18632/oncotarget.13983

Metrics: PDF 983 views  |   HTML 1327 views  |   ?  


Abstract

Kuikui Ge1,*, Jinjiang Huang1,*, Wei Wang1, Meigang Gu2, Xinchuan Dai1, Yuqiang Xu1, Hongyu Wu1,3, Guodong Li3, Hairong Lu3, Jiang Zhong1, Qingshan Huang1

1State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200433, China

2Laboratory of Virology and Infectious Disease Center for the Study of Hepatitis C, Rockefeller University, New York, NY 10065, USA

3Shanghai High-Tech United Bio-Technological R&D Co., Ltd, Shanghai 201206, China

*These authors contributed equally to this work

Correspondence to:

Qingshan Huang, email: qshuang@fudan.edu.cn

Keywords: SPINK6, HCC, tumor suppressor, invasion, proliferation

Received: April 11, 2016     Accepted: December 12, 2016     Published: December 16, 2016

ABSTRACT

Hepatocellular carcinoma (HCC) causes significant medical burdens worldwide. Diagnosis, especially in the early stages, is still challenging. Therapeutic options are limited and often ineffective. Although several risk factors have been known important for development of HCC, the molecular basis of the process is rather complex and has not been fully understood. We have found that a subpopulation of HCC cells which are resistant to oncolytic parvovirus H1 superinfection highly express serine protease inhibitor Kazal-type 6 (SPINK6). This protein is specifically reduced in all HCC cell lines and tissues we analyzed. When upregulated, SPINK6 could suppress the malignant phenotypes of the HCC cells in several in vitro models. The putative tumor suppression role of SPINK6 is, however, independent of its protease inhibitory activity. To suppress the malignancy of HCC cells, SPINK6 has to be secreted to trigger signals which regulate an intracellular signaling molecule, ERK1/2, as well as a series of downstream factors involved in cell cycle progression, apoptosis and migration. Our study supports that SPINK6 is an important tumor suppressor in liver, and further investigations may help develop more effective diagnostic and therapeutic approaches.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 13983